Ascendiant Capital Maintains Buy on Synergy CHC, Raises Price Target to $5.5

Benzinga Newsdesk www.benzinga.com Positive 86.4%

Neg 0% Neu 0% Pos 86.4%

Ascendiant Capital analyst Edward Woo maintains Synergy CHC (NASDAQ:SNYR) with a Buy and raises the price target from $5 to $5.5.